An interview with Dr Jerolen Naidoo, CSIR Senior Researcher
The human microbiome refers to the collection of microorganisms, such as bacteria and viruses that co-inhabit discrete sites across the human body. These microbes have emerged as critical determinants of health outcomes leading to the microbiome being referred to as our ‘second genome’. Adverse perturbations of the genetic and functional diversity of the human gut microbiome (dysbiosis) results in altered susceptibility and severity for a number of human diseases and can also influence treatment outcomes. The CSIR microbiome mapping initiative aims to explore this microbiome-human health axis within the South African population.